Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Biothrax Market Size Forecast: How Big Could The Market Get By 2030?
The biothrax market has shown significant expansion in recent years. Its size is anticipated to rise from $0.93 million in 2025 to $1.01 million in 2026, achieving a compound annual growth rate (CAGR) of 8.8%. Factors contributing to its historical growth include heightened awareness of bioterrorism threats, government-sponsored vaccine programs, mandatory military immunizations, past incidents of anthrax exposure, and the reliance on centralized vaccination campaigns.
The biothrax market is expected to show significant expansion in the upcoming years. It is projected to reach $1.4 million by 2030, growing at a compound annual growth rate (CAGR) of 8.5%. This growth throughout the forecast period can be attributed to several factors including increased investments in homeland security, a rise in global biodefense collaborations, the broadening of emergency preparedness policies, an increase in animal anthrax prevention programs, and the modernization of vaccine storage infrastructure. Notable trends during the forecast period involve a heightened focus on biodefense preparedness, the expansion of government stockpiling initiatives, more widespread use of pre-exposure prophylaxis vaccination, a growing emphasis on emergency response readiness, and the strengthening of national immunization security programs.
Get A Free Sample Report With In-Depth Market Insights:
Biothrax Market Growth Factors Behind Sustained Expansion
The rising consumption of meat is projected to fuel the expansion of the biothrax market. This increase in meat consumption stems from elements like growing urbanization, higher income levels, shifting dietary habits, and cultural customs that highlight meat as a key source of protein and nutrients. BioThrax serves as a vaccine for livestock to combat anthrax, a disease capable of spreading via tainted meat, thereby safeguarding meat products and shielding public health from zoonotic disease outbreaks. As an illustration, a report released in June 2023 by the Food and Agriculture Organization of the United Nations (FAO), a US-based agency focused on promoting food security, sustainable agriculture, and rural development, indicated that worldwide meat production climbed from 356.9 million metric tons in 2021 to 363.9 million metric tons in 2023, marking a 1.96% rise. More precisely, global bovine meat production saw an increase from 74.9 million metric tons in 2021 to 76.1 million metric tons in 2023. Consequently, the growing intake of meat is propelling the development of the biothrax market.
Biothrax Market Breakdown By Product Type And Application
The biothrax market covered in this report is segmented –
1) By Type: Live Vaccines, Cell Free Protective Antigen Vaccines
2) By Clinical Indication: Pre-Exposure Prophylaxis, Post-Exposure Prophylaxis
3) By Application: Human Use, Animal Use
4) By End-User: Hospital, Clinics, Vaccination Centers, Other End-Users
Biothrax Market Industry Trends Fueling Future Revenue Growth
A primary trend observed in the biothrax market involves directing strategic capital towards improving manufacturing capacity, broadening global reach, and creating next-generation anthrax vaccines. This strategic financial backing facilitates clinical studies and adherence to regulations, allowing businesses to secure authorizations across various nations. Consequently, this increases the accessibility of these vaccines in areas with unmet needs. As an illustration, in January 2024, the U.S. Department of Defense (DoD) granted Emergent BioSolutions, an American biotechnology firm, a substantial contract valued at up to $235.8 million for the provision of BioThrax (Anthrax Vaccine Adsorbed) to military personnel. This agreement highlights the continuous requirement for potent anthrax vaccines within the U.S. armed forces and demonstrates Emergent’s established partnership with governmental bodies in delivering biodefense remedies.
Biothrax Market Company Landscape And Competitive Strategy
Major companies operating in the biothrax market are Emergent Bio-Solutions
View The Full Biothrax Market Report:
Biothrax Market Geographic Analysis: Where Is Demand Accelerating Fastest?
North America was the largest region in the biothrax market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biothrax market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
